Is Emcure Pharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Emcure Pharmaceuticals Ltd (EMCURE.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Emcure Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Emcure Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Emcure Pharmaceuticals Ltd?

Muslim investors may consider investing in Emcure Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Emcure Pharmaceuticals Ltd classified as HALAL?

Musaffa determines the Shariah status of Emcure Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Emcure Pharmaceuticals Ltd updated?

The Shariah compliance status of Emcure Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Emcure Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Emcure Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Emcure Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Emcure Pharmaceuticals Ltd EMCURE.NS

₹1,704.90 ₹29.20 (1.74%) 1D

Last Updated: May 15, 12:00 AM·NSE

EMCURE.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 15, 2026

Report Source: 2026 3rd Quarter Report

Emcure Pharmaceuticals Ltd. Stock Analysis EMCURE.NS

India Health Care Mid Cap Report: Q3, 2026

Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. The company is headquartered in Pune, Maharashtra and currently employs 6,731 full-time employees. The company went IPO on 2024-07-10. The company offers a range of products and services under formulations, biologics and APIs. The company operates across a wide scope of areas, including gynecological, cardiology, antivirals, vitamins, pain/analgesics, anti-neoplastic, diabetes, anti-infective, respiratory, CNS and nephrology. Its brands include OROFER (Gynecological), BEVON (Vitamins), ZOSTUM (Anti- infectives), Ferium (Gynecological), EXHEP (Cardiovascular), Maxtra (Respiratory) and Pause (Blood-Related). Its API products include S-Amlodipine, Dydrogesterone, Ferric Carboxymaltose, Ferrous Ascorbate and Eribulin. Its biologics business offers various products, including Elaxim (cardiology), Vintor (nephrology), Xgrast (anti-neoplastic) and Pegex (anti- neoplastic). The company has developed two platforms: Mammalian and Microbial.

Key Statistics of Emcure Pharmaceuticals Ltd (EMCURE.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹1,659.90₹1,718.10

Today's Open

₹1,675.70

Volume

212.92K

P/E Ratio (TTM)

46.17

52 Week Range

₹1,013.40₹1,830.00

Market Cap

338.45B

Avg. Volume

359.92K

Dividend Yield

Financial Metrics & Statements of Emcure Pharmaceuticals Ltd (EMCURE.NS)

FAQ's for Emcure Pharmaceuticals Ltd (EMCURE.NS)

According to Musaffa’s Shariah screening methodology, Emcure Pharmaceuticals Ltd (EMCURE.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.